Pirtobrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

The requested reference [c790a075d0e14cac60bc60630fdee6f6ba3b5622] no longer exists in our database. It has been replaced by the current reference: [3b8761220c4b6302af8ef093a7dbfbfc09746bb1]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This trial is a prospective, multi-center, single-arm clinical research. The intention is to evaluate the efficacy and safety of pirtobrutinib combined with BEAM as a pretreatment regimen for ASCT in relapsed and refractory DLBCL patients.
Epistemonikos ID: acd434a147adcd908ccd8fac65058134d743f581
First added on: Aug 19, 2026